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The aim of this study was to create reliable models to 
predict the probability of achieving an ongoing pregnancy 
during in-vitro fertilization (IVF) treatment: model A, at 
the start of the first treatment, model B, at the time of 
embryo transfer, and model C, during the second treatment 
at the end of the first IVF treatment. Prognostic models 
were created using data from the University Hospital 
Nijmegen (n = 757) and applied to the data from the 
Catharina Hospital Eindhoven (n = 432), The Netherlands, 
to test their predictive performance. The predictions of 
model B (made at time of embryo transfer) were fairly 
good (c = 0.672 in the test population). For instance, 93% 
of the patients who had a predicted probability of achieving 
an ongoing pregnancy of <10% did not achieve an ongoing 
pregnancy. However, the predictions of the other two 
models (A and C) for Eindhoven were less reliable. The 
predictive value of model C was fairly high in Nijmegen 
(c = 0.673). Its poor performance in the test population 
may be explained partly by differences in effectiveness of 
the ovulation stimulation protocols and the decision about 
when to discontinue the cycle. Thus, before using prognostic 
models at an IVF centre, their reliability at that specific 
centre should be tested.
Key words: in-vitro fertilization/ongoing pregnancy/pregnancy/ 
prognosis/validation
Introduction
The probability that a patient will achieve an ongoing 
pregnancy should be evaluated as accurately as possible 
before a patient enters a programme for in-vitro fertilization 
(IVF) and during the course of her treatment with IVF. In 
addition to the age of the woman and the aetiology of 
infertility (the standard indicators for success), better rules 
would be welcome for physicians when counselling a patient. 
Potential predictors of IVF success are; patient characteristics 
at entry to the programme, characteristics of the treatment 
itself and during treatment, and intermediate results.
Most studies on factors that may predict pregnancy after 
treatment with IVF have investigated only a few indicators, 
for instance age and the type of infertility (Piette et a l, 1990; 
Hull et a l, 1992; Check et al, 1993), baseline follicle 
stimulating hormone (FSH), luteinizing hormone (LH) and 
oestradiof concentrations (Padilla et a l , 1990), ovulation 
stimulation treatment and ovarian response (Dor et a l , 1992), 
endometrium thickness and uterine artery flow (Spernol et a l , 
1993), sperm characteristics (Enginsu et a l 1992) and age, 
oestradiol concentration, number and quality of oocytes and 
embryos (Fluker et a l, 1993). However, various simultaneous 
factors may influence the probability of achieving an ongoing 
pregnancy after IVF It would therefore be desirable to create 
a model to predict the probability of achieving an ongoing 
pregnancy which includes all the relevant factors. Until now, 
only a few attempts have been made to do this for IVF (Hughes 
et a lt 1989; Haan et a l , 1991) and other assisted reproductive 
techniques (Guzick et a l, 1989; Nelson et a l , 1993). In the 
study by Hughes et al (1989), age and failed fertilization due 
to poor sperm quality had a predictive value for success in 
subsequent IVF cycles. Haan et al (1991) found that the 
probability of achieving an ongoing pregnancy after IVF 
treatment was increased by the presence of idiopathic infertility 
and decreased by the presence of a male factor, one ovary, the 
woman’s age ^  36 years, primary infertility of at least 5 years 
duration and by a higher number of previous IVF treatments. 
Multivariate prognostic models should not be confused with 
explanatory models such as recently published by Roseboom 
et al (1995). They discussed a multivariate model to explain 
the variation in the probability of pregnancy after embryo 
transfer. The variation was explained by the woman’s age, 
average embryo morphology score, number of transferred 
embryos and an interaction term between tubal pathology and 
the woman’s age. However, exclusion of the main effect of 
tubal pathology in the model makes a meaningful interpretation 
of the multivariate model difficult (Breslow and Day, 1980) 
and may cause bias (Kleinbaum et a l, 1982). Moreover, their 
statement in the results section '...with a 1 year increase of'age, 
the probability of pregnancy for non-tubal patients decreased by 
21%...' is obviously mistaken as a result of a wrong interpreta­
tion of the odds ratio in their study. Critical remarks can also 
be made about the methods used in the other four studies 
mentioned above (Guzick et a l , 1989; Hughes et a l , 1989; 
Haan et a l, 1991; Nelson et a l, 1993). All the cycles 
were combined, irrespective of the number of previous IVF 
treatments and the number of treatments per patient. Some 
studies based the inclusion of factors on statistical significance 
of the relationship in univariate analyses, which can be 
influenced by other factors, instead of on the increase in
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the predictive power in multivariate models. Moreover, the 
predictions of these models were never tested in other popula­
tions. Thus, the validity of these prognostic models when used 
at other IVF centres can be questioned.
The purpose of this study is to create reliable models to 
predict the probability of achieving an ongoing pregnancy 
during the first or second treatment cycles with IVF. We used 
data from the University Hospital Nijmegen, The Netherlands, 
to develop the models, and data from another centre to test 
their predictive value.
Materials and methods
To develop the prognostic models, data were used from couples who 
were treated by IVF for the first time in the period March 1991 to 
January 1995 at the University Hospital, Nijmegen, The Netherlands. 
During this period IVF treatment hardly changed. To test these 
models, data were used from the Catharina Hospital, Eindhoven, The 
Netherlands. Guidelines on indications for IVF treatment in the 
Netherlands have been described by Jansen (1993). In short, couples 
are only offered IVF treatment in case of bilateral tubopathology, in 
cases of unilateral tubopathology, male factor, endometriosis or 
cervical factor when other infertility treatments had not resolved the 
problem, and in case of idiopathic infertility after an infertility 
duration of at least 3 years. For both populations data were only 
included if the complete IVF treatment had been carried out at that 
particular IVF centre, no donor oocytes had been used and no intra- 
cytoplasmatic sperm injection (ICSI) had been performed. Patient 
characteristics prior to treatment are given in Table I.
Ongoing pregnancy was defined as a pregnancy which continued 
for longer than 12 weeks after embryo transfer. To predict the 
probability of achieving an ongoing pregnancy, three models were 
developed that employed different moments of prediction. To predict 
the probability of achieving an ongoing pregnancy during the first 
IVF treatment, model A was made at the start and model B at the 
time of embryo transfer. For the prognosis of achieving an ongoing 
pregnancy during the second IVF treatment, model C was created at 
the end of the first IVF treatment. Table II presents the number of 
patients and pregnancies at each prediction moment.
Model A
This model was based on predictions made at the start of the 
first IVF cycle regarding the probability of achieving an ongoing 
pregnancy during the first IVF cycle. To develop this model, data 
were available from 757 couples whose first IVF cycle took place in 
Nijmegen. To induce ovulation, all the patients received a long 
protocol of gonadotrophin-releasing hormone (GnRH) agonist (usually 
Leuprolide; Abbott B.V., Amstelveen, The Netherlands or Suprefact; 
Hoechst Holland N.V., Amsterdam, The Netherlands) that was started 
on day 21 of the previous cycle and human menopausal gonadotrophin 
(HMG, Humegon; Organon Int. B.V., Oss, The Netherlands). Addi­
tionally, from August 199.1 to January 1994, all the patients received 
oral contraceptives during the cycle that preceded the IVF cycle. To 
improve synchronization of follicle growth, some women received 
oral contraceptives before or after this period. To test the model, data 
were available from 432 couples from Eindhoven who underwent 
their first IVF treatment between January 1990 and June 1995 (another 
five couples were excluded from this population because information 
about the occurrence of an ongoing pregnancy was lacking). In this 
test population, the type of ovulation induction used most often 
(92.2%) was a short protocol of GnRH agonist (usually Suprefact;
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Hoechst Holland N.V.) and HMG (Humegon, Organon Int. B.V.), in 
a few cases supplemented by progestins in the preceding cycle.
Potential prognostic factors for the model that employed the onset 
of the first IVF cycle as the moment of prediction could only consist 
of information known at that moment, i.e. patient characteristics: age, 
period of infertility, reproductive history, basal FSH, indication(s) for 
IVF treatment, one or both ovaries present, sperm characteristics, 
anti-sperm antibodies in the woman or man, and information about 
the treatment protocol being used at that time: type of hormonal 
ovulation stimulation, maximum number of embryos that would 
be transferred, timing of human chorionic gonadotrophin (HCG) 
administration and type of culture medium. In Nijmegen, data on the 
duration of infertility were only available from patients who started 
IVF treatment between 1993-1994. Therefore the effect of the 
duration of infertility could only be estimated using the data from 
these 383 couples. Donor spermatozoa had not been used in Nijmegen, 
but it had been used in the test population in four and six patients during 
the first and second IVF cycles respectively. If donor spermatozoa had 
been used, the sperm characteristics were considered to be good and 
the indication for IVF ‘male factor’ was considered to be absent. We 
disregarded the results of cryopreserved embryo transfer.
Model B
Based on predictions made at the time of embryo transfer regarding 
the probability of achieving an ongoing pregnancy during the first 
IVF cycle. Only the data from couples who underwent embryo 
transfer during the first cycle were used to develop this model. Data 
were available from 604 (79.8% of the 757) couples from Nijmegen. 
To test the model, data could be used from 300 (69.4% of the 432) 
couples from Eindhoven, At this moment, information was added 
about preceding events during the cycle as potential prognostic 
factors, i.e. quality and number of oocytes retrieved, number of 
oocytes fertilized, quality and number of embryos transferred and 
whether the transfer had been uncomplicated as indicated by the use 
of a Wallace catheter, because in difficult cases a sdffer, Frydman 
catheter was used. In addition, information was known about the 
experience of the physician who performed the puncture and transfer; 
this could be used as a potential prognostic factor. Again, the results 
of cryopreserved embryo transfers were disregarded.
Model C
Based on predictions made at the end of the first IVF cycle regarding 
the probability of achieving an ongoing pregnancy during the second 
IVF cycle. To create this model, data were used from couples who 
did not have an ongoing pregnancy after the first IVF cycle or after 
a transfer of cryopreserved embryos and who started a second IVF 
cycle. In Nijmegen and in Eindhoven, 454 and 278 couples started a 
second IVF cycle respectively. In Eindhoven, information about 
ongoing pregnancy was lacking for three couples during the second 
cycle, so the data from 275 couples could be used for the test. In 
addition to the factors mentioned above, the pregnancy test result 
after the first IVF cycle was a potential prognostic factor in this model.
9
Statistical analysis
Models were developed by using logistic regression analysis. The 
first step was to develop a prognostic model based on patient 
characteristics and, if appropriate, the intermediate IVF treatment 
results, The second step was to evaluate whether treatment charac­
teristics added any prognostic value to the model. The third step was 
to test the model.
Criteria for accepting variables as predictive factors in the model 
were based on statistical significance and added prognostic value, 
evaluated by using the c index [i.e. (number of concordant pairs +
2299
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Table I, Patient characteristics of the populations at the start of the first in-vitro fertilization (IVF) cycle
Nijmegen (n = 757)
Min. Max. Mean SD
Woman’s age (years) 22 47 32.9 4.0
Duration of infertility (years)*1 0 20.5 4.4 2.8
Basal FSH (IU/1) < 0.6 23 6.1 2.8
n Percentage1*
5*1 Preceding gestations 256 33.8
S*1 Preceding spontaneous abortions 126 16.6
5s 1 Preceding ectopic pregnancies 62 8.2
5*1 Preceding deliveries 138 18.2
Indication for IVF
Tubal exclusively 168 22.2
Tubal and other(s) 137 18,1
Male factor exclusively 133 17,6
Male factor and other(s) 190 25,1
Endometriosis exclusively 44 5.8
. Endometriosis and other(s) 119 15.7
Cervical factor exclusively 27 3.6
Cervical factor and other(s) 91 12,0
Idiopathic infertility 138 18.2
Two ovaries 708 93,7
Sperm characteristics
a=20 X 106/ml 630 83,2
5*60% Normal forms 433 57,2
^50% Motile 416 55.0
Quality of motility =^4f 660 87.2
Anti-sperm antibodies, 6 or 9 66 8.7
In sperm 38 5.0
In woman’s serum 29 3.8
Use of donor spermatozoa 0 0.0
Median
33
4.0
5.7
162
29
23
50
147
42
94d
34e
34
33
1
1
96
395
NA
NA
NA
NA
10
NA
NA
4
Eindhoven (n = 432)
Min. Max. Mean SD Median
21 43 31.8 4.1 32
0 20.5 3.7 2.7 3.5
NA
n Percentage0
37.5
8.3
6,6
14.2
34.6 
9.9
22.1
8.0
8.0
7.8
0.2
0.2
22.6
93.4
2.3
0.9
NA = no information available.
^Number of missing values for duration of infertility in Nijmegen n = 374,
bNumber of missing values in Nijmegen: for two ovaries n ~ 1, anti-sperm antibodies $ or 9, and in sperm n ~ 2.
cNumber of missing values in Eindhoven: for 1 preceding spontaneous abortions, ectopic pregnancies, deliveries respectively n = 81, 81, 80, for the 
indications of IVF n — 7, for two ovaries n = 9. 
dDonor spermatozoa were used for three patients.
eDonor spermatozoa were used for one patient (the other indication for IVF was tubal factor), 
fOn a scale from 1 (worst) to 5 (best).
Table II. Number of patients and ongoing pregnancies
Nijmegen Eindhoven
No. Pregnancies
n %
No. Pregnancies
n
*
%
At start of first IVF 757 88 11.6 432 46 10.6
At embryo transfer of first IVF 604 88 14.6 300 46 15.3
At start of second IVF 454 61 - 13.4 275 29 10.5
a
IVF = in-vitro fertilization.
0.5 X the number of tied pairs)/total number of pairs] (Harrell et cil, 
1982; 1996). The c can be interpreted as the probability of a correct 
prediction for a random pair of a woman with an ongoing pregnancy 
and a woman without a pregnancy. It is equal to the area under a 
receiver operating characteristic (ROC) curve (Hanley and McNeil, 
1982). For the development of a prognostic model, the erroneous 
exclusion of any prognostic factors (because of too little power) 
would be more deleterious than including too many factors. Therefore 
these criteria were given a high and low cut-off point respectively; 
P <0.10 and c >0.005, The variables were selected according to a
method akin to a stepwise selection method, Here, the selection 
criteria is based not only on a P value (<  0.10), but also on a change 
in c (>  0.005). Special attention was given to multicollinearity. If 
this was present, only the variable with the highest predictive power 
was included in the multivariate model. If a variable did not meet 
the criteria in a univariate analysis, it thus could still be included in 
the prognostic model if the variable met the criteria when it was 
included in a multivariate model, i.e. after taking into account the 
prognostic value of other variables. In addition, a variable was omitted 
from the model if another factor was a stronger predictor and showed
2300
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Tabic III. Prognostic models for the probability of achieving an ongoing pregnancy (P) during the first in-vitro fertilization (IVF) or second IVF cycle
Model Ln [P/(1-P)l = SE(P) —21n(Lj/L2) 
df
Nijmegen 
at development
Eindhoven 
at testing
P value iVJ c Nd c
A -0.3350
+0.8151 X  5=1 preceding gestation 
—0.0620 X  woman’s age (years)
0.9503
0.2349
0.0297
14.04 
df — 2 
P = 0.0009
757 0.612 431 0.497
B -4,2034
+0.5290 X  5=1 preceding gestation 
+0.0630 X  no. fertilized oocytes 
+0.3464 X  no. transferred embryos 
+0.4377 X  no. transferred enjbryos
of at least good quality
0.5399
0.2422
0.0260
0.1711
0.1297
48.96 
df = 4 
P = 0.0001
603 0.721 171 0.672
C -4.0236
+0.9886 X  woman’s age ^30 years 
+0.6001 X  woman’s age 31-35 years 
—0.8412 X  idiopathic infertility 
+ 1.8638 X  embryo transfer during
first IVF cycle
0.7812
0.4146
0.3886
0.4537
0.7336
20.88 
df = 4 
P = 0.0003
454 0.673 271 0.528
»
“Patients with missing values on one or more of the variables were excluded, i.e. for Nijmegen 0, I and 0, and for Eindhoven 1, 129 and 4 for model A 
(prediction at start of first IVF cycle regarding probability during first cycle), model B (prediction at embryo transfer regarding probability during first cycle) 
and model C (prediction at end of first IVF cycle regarding probability during second cycle) respectively.
no additional predictive value. For sperm characteristics combined 
variables were created and their predictive value was evaluated 
against that of the separate sperm characteristics.
To test the predictive validity of the models, the data from the 
other centre were applied. As the data from Nijmegen contained more 
potential predictors than the data from Eindhoven, the models selected 
as the best predictive could not always be fully tested. If a specific 
variable was lacking, the model was modified, if possible, by 
exchanging it with a similar variable, or otherwise by excluding the 
variable. To evaluate the reliability of the model, the c was calculated. 
If the model had reasonable prognostic value, the predicted probability 
and the observed result of IVF were compared.
Results
B
The models for predicting the probability of achieving an 
ongoing pregnancy, developed with the data from Nijmegen 
and tested with the data from Eindhoven, are presented in 
Table HI.
Model A
During the first IVF cycle, 88 (11.6%) out of the 757 women 
from Nijmegen and 46 (10.6%) out of the 432 women from 
Eindhoven achieved an ongoing pregnancy. The only factors 
that had predictive value were a previous gestation and the 
woman’s age. During testing, this model did not show any 
predictive value when applied to the data from Eindhoven
(c = 0.497).
Model B
Embryo transfer was performed in 604 (79.8%) out of the 757 
couples from Nijmegen in the first IVF cycle. In Eindhoven, 
embryo transfer was performed in 300 (69.4%) out of the 432 
couples. The ongoing pregnancy rate per transfer was 14.6% 
in Nijmegen and 15.3% in Eindhoven. The prognostic model 
included the factors: at least one preceding gestation, the
number of fertilized oocytes, the number of transferred embryos 
and the number of transferred embryos of at least good quality. 
The probability of achieving an ongoing pregnancy increased 
if there had been a preceding gestation and the higher the 
numbers. During the test, this model showed good predictive 
value (c = 0.672) and good predictive performance, as shown 
in Table IV. For instance, 93% of the women with a predicted 
probability of achieving an ongoing pregnancy of <10% did 
not achieve an ongoing pregnancy after embryo transfer.
Model C
To predict the probability of achieving an ongoing pregnancy 
during the second IVF cycle, only the data from the couples 
who received a second treatment could be used. Of the 454 
couples who received a second IVF treatment in Nijmegen, 
61 (13.4%) achieved an ongoing pregnancy. In Eindhoven 
this occurred in 29 (10.5%) out of the 275 couples who 
underwent a second IVF treatment. The best prognostic 
model is shown in Table III. Of prognostic value were: the 
woman’s age in age-groups, the presence of idiopathic
#
infertility and embryo transfer during the first IVF cycle. 
However, this model did not show any predictive value in 
the test population (c = 0.528).
Discussion
This study showed that models for prediction of ongoing 
pregnancy due to IVF treatment can be developed with a fairly 
high prognostic value. However, this does not imply that the 
same models are predictive for patients treated at another 
clinic or even at the same clinic. Of the three models, only 
the one that made a prediction at the time of embryo transfer 
was fairly reliable in the other population. The other two 
models that made predictions at the start of treatment or after
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Table IV. Predicted and observed percentages and numbers of women with an ongoing pregnancy during the first in-vitro fertilization (IVF) treatment at the 
time of embryo transfer in Eindhoven
Observed
4
Predicted probability (%)
0-<5 5—<  10 10-< 15 15-<20 20-<25 25~<30 2*30 Total
Percentage ongoing pregnancy 0 8 16 19 23 25 50 15
No. women pregnant 0 5 6 6 3 2 3 25
Total number of women 16 60 37 31 13 8 6 17 l a
aNo prediction could be made for 129 women, bccause no information was available about the number of transferred embryos of at least good quality.
the first IVF cycle, however, seemed to be of little value when and specificity of a test. The predictive value of a positive test
used in Eindhoven. Although model B, which predicts at time is the proportion of patients with a positive test who achieve
of embryo transfer, is of little clinical importance, it gives an ongoing pregnancy, and the predictive value of a negative
information about the reasons for the inadequacy of the test is the proportion of the patients with a negative test who
prediction at the start of the cycle, For the two models at the do not achieve an ongoing pregnancy. Thus, they illustrate
start of the cycle, the ovarian response and oocyte aspiration whether the prognosis was right, whereas the sensitivity and
are very important, but cannot be included as prognostic factors 
in the models because this information is not available at the
specificity of a test indicate whether the patients who achieved 
an ongoing pregnancy were classified well by the test. All 
start of the treatment, whereas in the model that made a these measures can be easily calculated using the data of 
prediction at time of embryo transfer, the number and quality Table IV. For instance, assume the cut-off point for the test to 
of the retrieved oocytes are potential prognostic factors. be a predicted probability of 5%; the test is positive if the 
Therefore, one explanation for the poor reliability might be 
differences in the effectiveness of the ovulation simulation
predicted probability is 5^5% and negative it <5%. The 
positive predictive value of this test is 16% (25/155) and the
protocols, the long protocol of GnRH agonist in Nijmegen and negative predictive value is 100% (16/16). This demonstrates
the short protocol in Eindhoven. No oocyte aspiration was that the test can indicate patients who do not achieve an
performed during the first IVF treatment in 7,4% (56 out of ongoing pregnancy after IVF, but cannot predict who achieves
the 757) and 21.8% (94 out of the 432) of the women from an ongoing pregnancy. The sensitivity and specificity of this
Nijmegen and Eindhoven, respectively. During the second IVF test are 100% (25/25) and 11% (16/146) respectively.
treatment, these percentages were 4.6% (21 out of the 454) Obviously, clinicians select their patients before treatment
and 15.3% (42 out of the 275) respectively, Not only might with IVF. If the study populations had included more extreme
the effectiveness of the ovulation stimulation protocol have groups, those with a very high or a very low probability of
influenced the cancellation rate, but also the timing of this success, then the reliability of the prognosis would have been
decision differed between the two centres. During the first IVF better. The models we created only apply to populations that
cycle, the percentage of cancelled cycles for the reason of too lie within the range of the characteristics presented in Table
many follicles was only 1.8% in Nijmegen, but was as high I. As women of 40 years of age or older were poorly represented
as 31.5% in Eindhoven. This decision was made in Nijmegen in Nijmegen (n = 34), the models may not be valid for them,
if >25 follicles were present in combination with an oestradiol In addition, information on the duration of infertility was
concentration of >20 000 pmol/1, whereas in Eindhoven, cycles only available from 383 patients in Nijmegen. The potential 
were cancelled when >20 follicles were present. Whether the 
models developed in Nijmegen can make more accurate
prognostic effect of the duration of infertility might not have 
been detected because of too few observations,
predictions if they are applied to an IVF centre that uses a As the data were gathered retrospectively, it was not always
long protocol of GnRH agonist and with fewer cancelled possible to obtain full sets of information from the two
cycles remains to be seen. databases. In some cases data were missing, or they were not
The present models were adapted to make testing possible, present in the desired form. Moreover, the two hospitals had
given the information available in the test population. The their own method of performing IVF and the patient populations
changes were negligible. Models A and C were not changed might have differed on other aspects than those studied,
at all. In model B the number of follicles >15 mm was Therefore it was more difficult to create a model that would
initially included in the model, but because of lack of this make reliable predictions than if the data had been gathered
information in the Eindhoven population, it was exchanged in a standardized way for the purpose of prognostic studies at
with the number of fertilized oocytes. Moreover, in model B hospitals which use the same treatment protocols and the same
the sperm characteristics <60% normal forms and/or <20X106 definitions for each variable. To make it possible to create
spermatozoa per ml added minor predicting value, and were 
excluded from the model. Note that basal FSH had no additional
reliable prognostic models, we recommend setting up uniform 
national registries which also contain information about the
predictive value, nor had the indications for IVF, except for basic fertility workup.
idiopathic infertility in model C. The importance of testing prognostic models is evident.
For prognosis, the predictive value of a positive test and of Untested prognostic models can be worthless when used for 
a negative test are of more practical value than the sensitivity prediction at another (or possibly even the same) IVF clinic.
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Before a model can be used by another IVF centre, it should 
be tested with retrospective data from that centre, to establish 
whether it is a predictive model in that centre. Even before a 
model is implemented in the centre where it was developed, 
it should be tested with an entirely separate set of data from 
the same centre before one can rely on its predictive properties.
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